Open AccessConcerns and controversies regarding ipilimumab-based immunotherapy in the first-line treatment of non-small cell lung cancer
Author(s) -
Ivy Riano,
Narjust Duma
Publication year - 2021
Publication title -
precision cancer medicine
Language(s) - English
Resource type - Journals
ISSN - 2617-2216
DOI - 10.21037/pcm-2020-mnsclc-08
Subject(s) - ipilimumab , immunotherapy , medicine , lung cancer , oncology , cancer immunotherapy , cancer , nivolumab , immunology